Physician
Pathlink of New Jersey
Pathlink of New Jersey was paid $554K by Medicaid between Dec 2021 and Nov 2024, across 92 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 65% of everything it billed.
33Billing provider infoPATHLINK OF NEW JERSEY
DENVILLE, NJ 07834
DENVILLE, NJ 07834
33aNPI1538821327assigned 10/08/2021
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$554K
24GClaims115,231
24DCodes billed92
24AFirst – last monthDec 2021 – Nov 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in New Jersey
Rank by total paid#16 of 46
Median peer was paid$65K
This provider vs. median8.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 2,247 | $15K | |
| 2022 | 15,743 | $195K | |
| 2023 | 16,317 | $173K | |
| 2024incomplete | 80,924 | $171K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 65% | 7,169 | 6,540 | $359K |
| 88307 | 11% | 1,360 | 1,295 | $59K | |
| 80503 | 7.7% | 9,463 | 5,700 | $43K | |
| 88342 | 6.6% | 3,326 | 3,141 | $37K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4.3% | 1,097 | 1,035 | $24K |
| 88313 | 1.9% | 1,426 | 1,354 | $11K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 1,437 | 1,317 | $7K |
| 88304 | <1% | 324 | 304 | $4K | |
| G0452 | Molecular pathology procedure; physician interpretation and report | <1% | 314 | 293 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 632 | 600 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,108 | 1,838 | $2K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 307 | 278 | $2K |
80 more codes
| 80500 | <1% | 275 | $1K | |
| 80053 | Comprehensive metabolic panel | <1% | 11,444 | $830.07 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,979 | $332.35 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 131 | $280.00 |
| 82962 | <1% | 1,282 | $143.00 | |
| 88302 | <1% | 13 | $139.52 | |
| 87040 | <1% | 875 | $106.99 | |
| 84484 | <1% | 1,549 | $98.02 | |
| 87070 | <1% | 1,580 | $90.49 | |
| 83735 | <1% | 5,209 | $84.45 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,875 | $82.91 |
| 80320 | <1% | 269 | $81.78 | |
| 80061 | Lipid panel | <1% | 921 | $65.50 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 972 | $60.37 |
| 87077 | <1% | 330 | $48.48 | |
| 82947 | <1% | 1,999 | $47.89 | |
| 84100 | <1% | 3,440 | $44.47 | |
| 81003 | <1% | 3,136 | $39.52 | |
| 85027 | <1% | 1,963 | $38.73 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,842 | $38.28 |
| 83880 | <1% | 114 | $37.94 | |
| 83690 | <1% | 2,713 | $34.86 | |
| 87186 | <1% | 403 | $33.30 | |
| 83605 | <1% | 1,009 | $29.79 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 662 | $29.13 |
| 81001 | <1% | 2,933 | $27.56 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 752 | $24.90 |
| 85014 | <1% | 216 | $18.48 | |
| 87177 | <1% | 17 | $17.80 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 111 | $17.55 |
| 85007 | <1% | 1,064 | $16.91 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 924 | $15.28 |
| 84702 | <1% | 362 | $12.49 | |
| 82550 | <1% | 694 | $10.16 | |
| 81002 | <1% | 60 | $8.96 | |
| 85610 | <1% | 2,381 | $8.60 | |
| 85730 | <1% | 1,927 | $7.08 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,898 | $7.01 |
| 87205 | <1% | 300 | $3.43 | |
| 82607 | <1% | 17 | $2.94 | |
| 82728 | <1% | 96 | $2.73 | |
| 81025 | <1% | 1,672 | $2.00 | |
| 85045 | <1% | 39 | $1.39 | |
| 86140 | 0% | 62 | $0.00 | |
| 82150 | 0% | 52 | $0.00 | |
| 86592 | 0% | 483 | $0.00 | |
| 82077 | 0% | 281 | $0.00 | |
| 87390 | 0% | 82 | $0.00 | |
| 85652 | 0% | 171 | $0.00 | |
| 86901 | 0% | 17 | $0.00 | |
| 85379 | 0% | 477 | $0.00 | |
| 82803 | 0% | 88 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 195 | $0.00 |
| 83550 | 0% | 114 | $0.00 | |
| 81015 | 0% | 14 | $0.00 | |
| 84703 | 0% | 229 | $0.00 | |
| 87340 | 0% | 16 | $0.00 | |
| 82746 | 0% | 18 | $0.00 | |
| 86803 | 0% | 110 | $0.00 | |
| 87081 | 0% | 45 | $0.00 | |
| 83615 | 0% | 50 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 50 | $0.00 |
| 82553 | 0% | 13 | $0.00 | |
| 85651 | 0% | 15 | $0.00 | |
| 87420 | 0% | 13 | $0.00 | |
| 82248 | 0% | 588 | $0.00 | |
| 80143 | 0% | 210 | $0.00 | |
| 80076 | 0% | 426 | $0.00 | |
| 80179 | 0% | 205 | $0.00 | |
| 84439 | 0% | 245 | $0.00 | |
| 84145 | 0% | 121 | $0.00 | |
| 82010 | 0% | 17 | $0.00 | |
| 87631 | 0% | 132 | $0.00 | |
| 82247 | 0% | 955 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 60 | $0.00 |
| 80354 | 0% | 118 | $0.00 | |
| 87634 | 0% | 16 | $0.00 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 96 | $0.00 |
| 83540 | 0% | 19 | $0.00 | |
| 86900 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGONZALEZ, MARIO (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Princeton Pathology Services PA | Newark, NJ | $1.08M |
| Pathlink of New Mexico LLC | Las Cruces, NM | $379K |
| Pathlink of Texas, PLLC | El Paso, TX | $233K |
| Huron Pathology Associates PLLC | Port Huron, MI | $162K |
| Pathlink of Ohio LLC | Sandusky, OH | $39K |
| Garden State Physician Associates LLC | Vineland, NJ | $9K |
| Princeton Pathology Services PLLC | Bristol, PA | $7K |
| GT Psychiatry LLC | San Juan, PR | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.